Physician profile
Thomas P Beveridge
NPI 1396712840
$7,824.97
in general payments reported to CMS, 2019-2025
24 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,809 · 2020: $180 · 2021: $92.95 · 2022: $1,113 · 2023: $1,585 · 2024: $589 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,092 · Travel and Lodging: $468 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,092.05 |
| Travel and Lodging | $468.18 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,791.05 | 2019 | |
| Medtronic, INC. | $1,741.58 | 2022-2025 | Arctic Front Advance, Selectsecure, Harmony |
| Medical Device Business Services, INC. | $1,425.00 | 2019 | |
| Boston Scientific Corporation | $485.74 | 2019-2024 | Bodyguardian, Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $448.23 | 2019-2024 | |
| Abbott Laboratories | $371.66 | 2020-2025 | Ensite, Aveir, Ensite Precision |
| E.R. Squibb & Sons, L.L.C. | $282.00 | 2019-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $267.63 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $224.23 | 2019-2024 | Xarelto |
| Itamar Medical INC | $152.64 | 2022-2025 | Watchpatone |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.04 | 2019-2023 | Lifevest |
| Lundbeck LLC | $93.02 | 2019 | |
| Irhythm Technologies, INC. | $74.47 | 2020-2023 | Zio Xt Patch |
| Baxter Healthcare | $74.20 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Biosense Webster, INC. | $54.07 | 2022-2024 | Qdot Micro |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $50.90 | 2023-2024 | (Ck7) Extended Holter |
| Zoll Respicardia, INC. | $46.79 | 2023 | Remede System |
| Covidien LP | $43.57 | 2020 | |
| Braemar Manufacturing, LLC | $37.09 | 2019 | |
| Cordis US Corp. | $22.25 | 2025 | Mynx Control Venous |
| Elutia, INC. | $13.85 | 2019 | |
| Altathera Pharmaceuticals LLC | $12.82 | 2023 | Sotalol Hydrochloride |
| Alnylam Pharmaceuticals INC. | $12.43 | 2019 | |
| Bardy Diagnostics, INC. | $5.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Beveridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.